7
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The Norplant experience at the University Hospital of the West Indies

Pages 569-572 | Published online: 02 Jul 2009

  • Abdulla K. A., Elwan S. I., Salem H. S. and Shaaban M. M. (1985) Effect of early postpartum use of the contrace ptive implants, Norplant, on the serum levels of immunoglob ulins of the mothers and their breastfed infants. Contracep tion, 32, 261-266.
  • Affandi B., Lubis F., Prihartono J., Sutedi H. and Suyono H. (1987) Introduction of Norplan t into a family planning programme: Indonesi an experience. 12 pp. Unpub lished.
  • Bardin C. W. and Sivin I. (1985) Norplant contrace ptive implants: a new contrace ptive for women. IPPF Medical Bulletin, 19, 2-4.
  • Croxatto H. B., Diaz S., Robertso n D. N. and Pavez M. (1983)Clinicalchemistryinwomentreatedwith levonorgestrel implants (Norplant) or a TCu 200 IUD. Contraception, 27, 281-288.
  • Croxatto H. B., Diaz S., Pavez M., Cardenas H., Larsson M. andJohansso nE. D. B. (1988) Clearanceof levonorgestrel from the circulat ion following removal of Norplan t subder mal implants. Contracep tion, 38, 509-523.
  • Diaz S., Herreros C., Juez G., Casado M. E., Salvatierra A. M., Miranda P., Peralta O. and Croxatto H. B. (1985) Fertility regulation in nursin g women: 7. In¯ uence of Norplan tlevonor gestre luponlactatio nandinfant growth. Contracep tion, 32, 53-74.
  • Haiba N., El-Sahwi M. S. and Toppozad a M. (1984) Metabolic change s during Norplan t use. In: The Norplant Subdermal Contracep tive System, edited by M. M. Shaa-ban, pp. 107-114. Assiut, Egypt, Assiut University.
  • Holma P. and Robertso n D. N. (1985) Cholesterol and HDL-choleste rol values in women during use of subdermal implants releasin g levonorgestrel. Contraception, 32, 163-171.
  • Shikary Z. K., Betrabett S. S., Toddywala W. S., Patel D. M., Datey S. and Saxena B. N. (1986) Pharmacody namic effects of levonorgestrel administered either orally or subder mally to early postpartum lactatin g mothers on the urinary levels of follicle stimulating hormone (FSH), luteiniz ing hormone (LH) and testoster one (T) in their breast-fed male infants. Contraception, 34, 403-412.
  • Kelly S. (1987) Insertin g and removing Norplant implants. (Robert Wood Johnso n School of Medicine). Personal communicatio n.
  • Kurunmaki H. (1983) Contraception with levonorgestrel-releasing subder mal capsules , Norplant, after pregnan cy termination. Contracep tion, 27, 473-482.
  • Lubis F., Prihartono J., Agoestin a T., Affandi B. and Sutedi H. (1983) One-year experience with Norplan t implants in Indonesi a. Studies in Family Plannin g, 14, 181-184.
  • Population Council (1986b ) Acceptor s describ e what they like, dislike, want to know about Norplant method. Nor-plant Worldwide, 4, p. 3.
  • Population Council (1986a) Norplant fact sheet. Norplant W orldw ide, 5, pp. 2-4.
  • PopulationCouncil(1983)NorplantContracep tive Implants: Instructi ons for Clinician s. New York, popu lation Council. 17 pp.
  • Roy S., Mishell D. R., Jr, Robertson D. N., Krauss R. M., Lacarra M. and Duda M. J. (1984) Long term reversib le contraception with levonor gestel-releasin g Silastic rods. American Journa l of Obstetrics and Gynaecology, 148, 1006-1013.
  • Satayapa n S., Kanchanas inith K. and Varakamin S. (1983) Perceptio ns and acceptab ility of Norplant implants in Thailand. Studie s in Family Plannin g, 14, 170-176.
  • Shaaban M. M., Elwan S. I., Abdalla S. A. and Darwish H. A. (1984a ) Effect of subder mal levonor gestrel contra-ceptiv e implants, Norplant , on serum lipids. Contraception, 30, 413-419.
  • Shaaban M. M., Elwan S. I., El-Sharkawy M. M. and FarghalyA.S.(1984b )Effectofsubder mal levonorgestrel contrace ptive implants, Norplant, on liver functio ns. Contraception, 30, 407-412.
  • Sivin I., Sanchez F. A., Diaz S., Holma P., Coutinh o E., McDonald O., Robertso n D. N. and Stern J. (1983) Three-year experien ce with Norplan t subder mal contraception. Fertility and Sterility, 39, 799-808.
  • WorldHealthOrganisati on.Specialprogrammeof research , develop ment and researc h training in human reprodu ction (1985) Facts about an implantable contraceptive: memorandu m for a WHO meeting. Bulletin of the World Health Organisati on, 63, 485-494.
  • Zimmerman M. (1985) Notes for a talk on Norplant acceptability at the Norplan t User Perspective Meeting. New York, Population Council.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.